Effect of endothelial cells and transforming growth factor-ß1 on cultured vascular smooth muscle cell growth patterns
- 30 November 1994
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 20 (5) , 787-794
- https://doi.org/10.1016/s0741-5214(94)70166-0
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions.Journal of Clinical Investigation, 1992
- Identification of the phenotypic modulation of rabbit arterial smooth muscle cells in primary culture by flow cytometryExperimental Cell Research, 1992
- Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase‐type PA, PA inhibitor‐1 mRNA, and protein in rat osteoblast‐like cellsJournal of Cellular Physiology, 1991
- Production of transforming growth factor beta 1 during repair of arterial injury.Journal of Clinical Investigation, 1991
- TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loopCell, 1990
- Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta.The Journal of cell biology, 1990
- Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture.The Journal of cell biology, 1989
- Transforming growth factor β alters plasminogen activator activity in human skin fibroblastsExperimental Cell Research, 1986
- Normal embryo fibroblasts release transforming growth factors in a latent formJournal of Cellular Physiology, 1984
- What controls smooth muscle phenotype?Atherosclerosis, 1981